Optimising Success for Access to Rare Disease Treatments

If you missed our latest webinar on the changing landscape of Highly Specialised Technologies in the UK it’s not too late to catch up. View the presentation slides here to see excerpts about overcoming hurdles in the NICE process and our thoughts and considerations on what it takes a Managed Access Agreement (MAA) successful.

Previous
Previous

A Consensus Statement: Psychological Support at Diagnosis